SCHEMBL2278746

SCHEMBL2278746

COc1cc(B2OC(C)(C)C(C)(C)O2)cc(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.43
CA9 Q16790 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CSF1R P07333 1/20 0.40
PTGS2 P35354 1/20 0.39
LPL P06858 5/20 0.39
LIPG Q9Y5X9 5/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTAFR P25105 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17320566 0.90 CSF1R (0.40) ACHECA9CYP3A4MAPTCSF1R
SCHEMBL22726982 0.85 CSF1R (0.43) CA9CSF1RLPLLIPGMEN1
SCHEMBL16655447 0.84 FPR2 (0.37) ACHECA9CSF1RLPLLIPG
SCHEMBL28855603 0.84 PDE4A (0.38) CYP3A4MAPTCSF1RPTGS2LPL
SCHEMBL20600668 0.83 CA1 (0.40) CA9CYP3A4MAPTCSF1RPTGS2
SCHEMBL1129266 0.81 LPL (0.45) CA9CSF1RLPLLIPGALDH1A1
SCHEMBL24204614 0.80 CSF1R (0.38) CA9CSF1RLPLLIPGCA1
SCHEMBL16886087 0.80 CSF1R (0.40) CA9CYP3A4CSF1RLPLLIPG
SCHEMBL26851003 0.80 PDE5A (0.39) MAPTALDH1A1HPGDL3MBTL1MEN1
SCHEMBL26850941 0.80 CA1 (0.39) CA9CSF1RALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559310-B2 Reacting a halogen aromatic derivative at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a suitable base for covalently coupling organic compounds COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2003-05-06 US claimed
US-20020193604-A1 Aryl borates COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-12-19 US claimed
US-20250129016-A1 PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2025-04-24 US disclosed
EP-2935253-B1 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS LTD (CA) 2018-08-01 EP disclosed
US-9861637-B2 Heterocyclic compounds as bromodomain inhibitors ZENITH EPIGENETICS LTD. (CA) 2018-01-09 US disclosed
US-20170143731-A1 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS LTD. 2017-05-25 US disclosed
US-9598367-B2 Heterocyclic compounds as bromodomain inhibitors ZENITH EPIGENETICS LTD. (CA) 2017-03-21 US disclosed
US-20160130228-A1 Novel Heterocyclic Compounds as Bromodomain Inhibitors ZENITH EPIGENETICS LTD. (CA) 2016-05-12 US disclosed
US-9290435-B2 Molecular glass of spirofluorene derivative, preparation method thereof and use thereof in photo-etching Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences (CN) 2016-03-22 US disclosed
US-9271978-B2 Heterocyclic compounds as bromodomain inhibitors ZENITH EPIGENETICS CORP. (CA) 2016-03-01 US disclosed
US-20150353468-A1 MOLECULAR GLASS OF SPIROFLUORENE DERIVATIVE, PREPARATION METHOD THEREOF AND USE THEREOF IN PHOTO-ETCHING Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences (CN) 2015-12-10 US disclosed
US-8530689-B2 Processes for the preparation of biphenyl compounds THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-09-10 US disclosed
US-20110207957-A1 PROCESSES FOR THE PREPARATION OF BIPHENYL COMPOUNDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2011-08-25 US disclosed
US-20110207957-A1 PROCESSES FOR THE PREPARATION OF BIPHENYL COMPOUNDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2011-08-25 US disclosed
US-20110207957-A1 PROCESSES FOR THE PREPARATION OF BIPHENYL COMPOUNDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2011-08-25 US disclosed
WO-2009137322-A2 PROCESSES FOR THE PREPARATION OF BIPHENYL COMPOUNDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-11-12 WO disclosed
US-7122694-B2 Hydroboronation process BORON MOLECULAR PTY LIMITED (AU) 2006-10-17 US disclosed
US-20040133028-A1 Hydroboronation process COMMONWEALTH SCIENTIFIC 2004-07-08 US disclosed
EP-1127060-B1 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2004-04-07 EP disclosed
US-6680401-B1 BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130228-A1 Novel Heterocyclic Compounds as Bromodomain Inhibitors BRD4, BRDT, BRD3 ACHE 4706/4885CA9 4802/4885CYP3A4 4590/4885
US-20110207957-A1 PROCESSES FOR THE PREPARATION OF BIPHENYL COMPOUNDS C1S, BAX, C9 ACHE 2994/4885CA9 2704/4885CYP3A4 41/4885
US-20020193604-A1 Aryl borates BRD4, ABL1, BRD3 ACHE 2773/4885CA9 643/4885CYP3A4 57/4885
US-20170143731-A1 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS BRD4, BRDT, BRD3 ACHE 4706/4885CA9 4802/4885CYP3A4 4590/4885
US-20040133028-A1 Hydroboronation process ALKBH3, HPD, HVCN1 ACHE 4587/4885CA9 928/4885CYP3A4 80/4885
US-20250129016-A1 PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF RCC2, PPOX, FTO ACHE 3507/4885CA9 54/4885CYP3A4 110/4885
US-20150353468-A1 MOLECULAR GLASS OF SPIROFLUORENE DERIVATIVE, PREPARATION METHOD THEREOF AND USE THEREOF IN PHOTO-ETCHING PDGFRA, ARHGEF12, GLI2 ACHE 4780/4885CA9 2692/4885CYP3A4 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.